ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,865Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 168

$1.88M Total Retail Price of All Prescriptions

Rank: 1 out of 168

770 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 770 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

13% of this provider’s 770 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 17,450 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $114 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
LEVOTHYROXINE SODIUM 906 767 1 15
FUROSEMIDE 772 670 2 2
ENALAPRIL MALEATE 590 480 3 32
CALCITRIOL 588 502 4 6
PRAVASTATIN SODIUM 580 443 5 27
OMEPRAZOLE 541 430 6 12
HYDROCHLOROTHIAZIDE 457 398 7 20
SIMVASTATIN 425 367 8 8
ATORVASTATIN CALCIUM 419 372 9 19
HYDROCODONE-ACETAMINOPHEN 415 263 S3 10 18
METOPROLOL SUCCINATE 411 376 11 16
GABAPENTIN 405 249 12 26
CARVEDILOL 376 332 13 11
POTASSIUM CHLORIDE 367 325 14 30
LOSARTAN POTASSIUM 363 278 15 10
METOPROLOL TARTRATE 359 281 16 7
LANTUS 348 190 17 37
ZOLPIDEM TARTRATE 344 263 18 40
INSULIN SYRINGE 294 158 19 42
PREDNISONE 284 212 20 23
WARFARIN SODIUM 281 252 21 31
PANTOPRAZOLE SODIUM 278 179 22 39
CRESTOR 273 232 23 41
NIFEDIPINE ER 259 165 24 28
ALLOPURINOL 240 205 25 13
LISINOPRIL 240 207 25 3
PAROXETINE HCL 238 212 27 88
TRAMADOL HCL 226 176 28 35
METFORMIN HCL 217 178 29 29
AMLODIPINE BESYLATE 214 187 30 1
RENVELA 188 91 31 4
ZETIA 183 151 32 68
CLONIDINE HCL 177 112 33 9
NEXIUM 174 130 34 43
JANUVIA 171 154 35 46
LABETALOL HCL 171 107 35 48
TAMSULOSIN HCL 168 141 37 36
METOCLOPRAMIDE HCL 159 91 38 70
SERTRALINE HCL 152 131 39 52
ALENDRONATE SODIUM 148 128 40 49
SPIRONOLACTONE 144 96 41 25
NIFEDICAL XL 138 82 42 85
LOVASTATIN 137 106 43 109
LANTUS SOLOSTAR 135 83 44 95
HUMULIN N 134 108 45 66
FAMOTIDINE 133 110 46 57
MIDODRINE HCL 128 71 47 75
COLCRYS 127 112 48 76
HUMALOG 126 71 49 92
DOXAZOSIN MESYLATE 122 101 50 21
DIOVAN 116 80 51 24
HYDROXYCHLOROQUINE SULFATE 114 102 52 121
GLIPIZIDE 113 100 53 45
TRAZODONE HCL 111 63 54 81
GLYBURIDE 108 90 R 55 130
CYCLOBENZAPRINE HCL 106 38 R 56 67
SENSIPAR 105 43 57 5
LIPITOR 104 74 58 103
CITALOPRAM HBR 103 76 59 59
CYMBALTA 99 49 60 90
PRADAXA 99 99 60 134
ROPINIROLE HCL 97 59 62 71
OXYCODONE HCL 95 64 S2 63 83
BUMETANIDE 93 63 64 34
NAMENDA 89 89 65 93
PEN NEEDLE 87 55 66 105
MELOXICAM 86 86 67 71
SINGULAIR 84 58 68 103
DEXILANT 83 28 69 141
TOPIRAMATE 83 48 69 79
TERAZOSIN HCL 82 80 71 60
CEPHALEXIN 76 50 72 91
ATENOLOL 76 57 72 38
AMITRIPTYLINE HCL 76 64 R 72 62
SULFAMETHOXAZOLE-TRIMETHOPRIM 74 50 75 54
FLUTICASONE PROPIONATE 72 45 76 96
GLIPIZIDE ER 72 72 76 77
MIRTAZAPINE 72 70 76 73
FINASTERIDE 72 70 76 61
POLYETHYLENE GLYCOL 3350 71 55 80 108
DIVALPROEX SODIUM 71 43 80 112
FENOFIBRATE 70 45 82 117
ADVAIR DISKUS 70 61 82 74
METHADONE HCL 70 35 S2 82 144
AMIODARONE HCL 68 58 85 145
BUPROPION HCL SR 64 30 86 148
HUMULIN 70-30 62 55 87 118
HUMULIN R 61 44 88 124
METHOTREXATE 61 61 88 152
AZITHROMYCIN 61 53 88 84
NOVOLIN N 60 41 91 154
NOVOLOG 60 26 91 154
DIGOXIN 60 57 91 79
DILTIAZEM 24HR ER 59 59 94 129
PLAVIX 59 35 94 158
BUSPIRONE HCL 59 47 94 158
OXYCODONE-ACETAMINOPHEN 59 26 S2 94 55
BENICAR 58 55 98 162
MONTELUKAST SODIUM 58 44 98 123
TRIAMTERENE-HCTZ 55 47 100 86
ACTOS 55 45 100 119
ISOSORBIDE MONONITRATE ER 55 48 100 50
LOSARTAN-HYDROCHLOROTHIAZIDE 54 54 103 53
QUETIAPINE FUMARATE 54 53 103 116
DONEPEZIL HCL 53 53 105 65
RANITIDINE HCL 52 22 106 51
CLOPIDOGREL 52 37 106 78
FLUDROCORTISONE ACETATE 52 40 106 172
HYDROXYZINE HCL 51 41 R 109 115
HYDRALAZINE HCL 51 26 109 14
DICYCLOMINE HCL 51 24 109 176
KLOR-CON M10 50 43 112 131
PROMETHAZINE HCL 50 0 R 112 178
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.